Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Milpied

Showing results (161-170 of 240) with videos related to

Pageof 24
Sort By:
British Journal of Haematology|September 13, 2001
Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graftH Tayebi, V Lapierre, P Saas, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2000
Salvage extended-field irradiation in follicular non-Hodgkin's lymphoma after failure of chemotherapyM a Mahé, S Bourdin, A Le Pourhiet-Le Mevel, et al.
Bone Marrow Transplantation|June 4, 2013
Allogeneic SCT for patients with high-risk peripheral T-cell lymphoma in first responseM Robles, S Vigouroux, R Tabrizi, et al.
British Journal of Haematology|October 16, 1999
Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database. Sociét Française de Greffe de MoelleN Dhedin, S Giraudier, P Gaulard, et al.
Occupational and Environmental Medicine|November 20, 2008
Occupational exposure to pesticides and lymphoid neoplasms among men: results of a French case-control studyL Orsi, L Delabre, A Monnereau, et al.
Leukemia|September 20, 2014
Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working PartyA Tanase, N Schmitz, H Stein, et al.
Leukemia|June 18, 2015
Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)A Pigneux, M Labopin, J Maertens, et al.
Bone Marrow Transplantation|June 6, 2017
Severe acute GvHD following administration of ipilimumab for early relapse of AML after haploidentical stem cell transplantationF-X Gros, T Cazaubiel, E Forcade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, FranceC Foussard, B Desablens, L Sensebe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomasK Bouabdallah, S Furst, J Asselineau, et al.
Pageof 24

Showing results (161-170 of 240) with videos related to

Sort By:
Pageof 24
British Journal of Haematology|September 13, 2001
Enhanced activation of B cells in a granulocyte colony-stimulating factor-mobilized peripheral blood stem cell graftH Tayebi, V Lapierre, P Saas, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2000
Salvage extended-field irradiation in follicular non-Hodgkin's lymphoma after failure of chemotherapyM a Mahé, S Bourdin, A Le Pourhiet-Le Mevel, et al.
Bone Marrow Transplantation|June 4, 2013
Allogeneic SCT for patients with high-risk peripheral T-cell lymphoma in first responseM Robles, S Vigouroux, R Tabrizi, et al.
British Journal of Haematology|October 16, 1999
Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database. Sociét Française de Greffe de MoelleN Dhedin, S Giraudier, P Gaulard, et al.
Occupational and Environmental Medicine|November 20, 2008
Occupational exposure to pesticides and lymphoid neoplasms among men: results of a French case-control studyL Orsi, L Delabre, A Monnereau, et al.
Leukemia|September 20, 2014
Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working PartyA Tanase, N Schmitz, H Stein, et al.
Leukemia|June 18, 2015
Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)A Pigneux, M Labopin, J Maertens, et al.
Bone Marrow Transplantation|June 6, 2017
Severe acute GvHD following administration of ipilimumab for early relapse of AML after haploidentical stem cell transplantationF-X Gros, T Cazaubiel, E Forcade, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Is the International Prognostic Index for aggressive lymphomas useful for low-grade lymphoma patients? Applicability to stage III-IV patients. The GOELAMS Group, FranceC Foussard, B Desablens, L Sensebe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomasK Bouabdallah, S Furst, J Asselineau, et al.
Pageof 24